High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients with Suspected Acute Coronary Syndrome

Circulation

Volumn 140, Issue 19, 2019, Pages 1557-1568

  Bularga, Anda ^a   Lee, Kuan Ken ^a   Stewart, Stacey ^a   Ferry, Amy V ^a   Chapman, Andrew R ^a   Marshall, Lucy ^a   Strachan, Fiona E ^a   Cruickshank, Anne ^b   Maguire, Donogh ^c   Berry, Colin ^d   Findlay, Iain ^e   Shah, Anoop S V ^a   Newby, David E ^a   Mills, Nicholas L ^a   Anand, Atul ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b QUEEN ELIZABETH UNIVERSITY HOSPITAL   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e ROYAL ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

acute coronary syndrome; myocardial infarction; risk stratification; troponin

Indexed keywords

HIGH SENSITIVITY TROPONIN I; TROPONIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAM; ENZYME ASSAY; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCEPTIVE THRESHOLD; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK STRATIFICATION THRESHOLD; SAFETY; SENSITIVITY ANALYSIS; BLOOD; CAUSE OF DEATH; ELECTRONIC HEALTH RECORD; MIDDLE AGED; MORTALITY; PROGNOSIS; RISK FACTOR; SCOTLAND; TIME FACTOR; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CAUSE OF DEATH; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SCOTLAND; TIME FACTORS; TROPONIN I;

EID: 85074552934     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.119.042866     Document Type: Article

References (47)

1. Apple FS, Collinson PO, IFCC Task Force on Clinical Applications of Cardiac Biomarkers Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012 58 54 61. doi: 10.1373/clinchem.2011.165795
2. Mills NL, Omland T, Cardiac troponin to guide the use of noninvasive testing in patients ruled out for myocardial infarction. Circulation 2019 139 1655 1657. doi: 10.1161/CIRCULATIONAHA.118.038162
3. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, ESC Scientific Document Group 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016 37 267 315. doi: 10.1093/eurheartj/ehv320
4. Carlton E, Greenslade J, Cullen L, Body R, Than M, Pickering JW, Aldous S, Carley S, Hammett C, Kendall J, Evaluation of high-sensitivity cardiac troponin I levels in patients with suspected acute coronary syndrome. JAMA Cardiol 2016 1 405 412. doi: 10.1001/jamacardio.2016.1309
5. Neumann JT, Twerenbold R, Ojeda F, Sörensen NA, Chapman AR, Shah ASV, Anand A, Boeddinghaus J, Nestelberger T, Badertscher P, Application of high-sensitivity troponin in suspected myocardial infarction. N Engl J Med 2019 380 2529 2540. doi: 10.1056/NEJMoa1803377
6. Shah AS, Anand A, Sandoval Y, Lee KK, Smith SW, Adamson PD, Chapman AR, Langdon T, Sandeman D, Vaswani A, High-STEACS investigators High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 2015 386 2481 2488. doi: 10.1016/S0140-6736(15)00391-8
7. Crea F, Jaffe AS, Collinson PO, Hamm CW, Lindahl B, Mills NL, Thygesen K, Mueller C, Patrono C, Roffi M, 2015 ESC NSTE-ACS Guidelines Task Force Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally? Eur Heart J 2016 37 3316 3323. doi: 10.1093/eurheartj/ehw282
8. Chapman AR, Lee KK, McAllister DA, Cullen L, Greenslade JH, Parsonage W, Worster A, Kavsak PA, Blankenberg S, Neumann J, Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome. JAMA 2017 318 1913 1924. doi: 10.1001/jama.2017.17488
9. Pickering JW, Than MP, Cullen L, Aldous S, Ter Avest E, Body R, Carlton EW, Collinson P, Dupuy AM, Ekelund U, Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis. Ann Intern Med 2017 166 715 724. doi: 10.7326/M16-2562
10. Goodacre S, Cross E, Arnold J, Angelini K, Capewell S, Nicholl J, The health care burden of acute chest pain. Heart 2005 91 229 230. doi: 10.1136/hrt.2003.027599
11. Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K, Wibberley C, Nuttall M, Mackway-Jones K, Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011 58 1332 1339. doi: 10.1016/j.jacc.2011.06.026
12. Body R, Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, de Filippi CR, Nowak R, Panteghini M, Jernberg T, Plebani M, TRAPID-AMI Investigators The use of very low concentrations of high-sensitivity troponin T to rule out acute myocardial infarction using a single blood test. Acad Emerg Med 2016 23 1004 1013. doi: 10.1111/acem.13012
13. Boeddinghaus J, Nestelberger T, Twerenbold R, Wildi K, Badertscher P, Cupa J, Bürge T, Mächler P, Corbière S, Grimm K, Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I. Circulation 2017 135 1597 1611. doi: 10.1161/CIRCULATIONAHA.116.025661
14. Carlton EW, Cullen L, Than M, Gamble J, Khattab A, Greaves K, A novel diagnostic protocol to identify patients suitable for discharge after a single high-sensitivity troponin. Heart 2015 101 1041 1046. doi: 10.1136/heartjnl-2014-307288
15. Sandoval Y, Jaffe AS, Using high-sensitivity cardiac troponin T for acute cardiac care. Am J Med 2017 130 1358 1365.e1. doi: 10.1016/j.amjmed.2017.07.033
16. Kavsak PA, Don-Wauchope AC, Hill SA, Worster A, Acceptable analytical variation may exceed high-sensitivity cardiac troponin I cutoffs in early rule-out and rule-in acute myocardial infarction algorithms. Clin Chem 2016 62 887 889. doi: 10.1373/clinchem.2016.255448
17. Kavsak PA, Jaffe AS, Greene DN, Christenson RH, Apple FS, Wu AHB, Total analytic error for low cardiac troponin concentrations (≤10 ng/L) by use of a high-sensitivity cardiac troponin assay. Clin Chem 2017 63 1043 1045. doi: 10.1373/clinchem.2017.271361
18. Body R, Reynard C, One shot to rule out: does the limit of detection of a high-sensitivity troponin assay hit the mark? Clin Chem 2017 63 21 23. doi: 10.1373/clinchem.2016.266460
19. Shah ASV, Anand A, Strachan FE, Ferry AV, Lee KK, Chapman AR, Sandeman D, Stables CL, Adamson PD, Andrews JPM, High-STEACS Investigators High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet 2018 392 919 928. doi: 10.1016/S0140-6736(18)31923-8
20. Chapman AR, Anand A, Boeddinghaus J, Ferry AV, Sandeman D, Adamson PD, Andrews J, Tan S, Cheng SF, D'Souza M, Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction. Circulation 2017 135 1586 1596. doi: 10.1161/CIRCULATIONAHA.116.025021
21. Chapman AR, Hesse K, Andrews J, Ken Lee K, Anand A, Shah ASV, Sandeman D, Ferry AV, Jameson J, Piya S, High-sensitivity cardiac troponin I and clinical risk scores in patients with suspected acute coronary syndrome. Circulation 2018 138 1654 1665. doi: 10.1161/CIRCULATIONAHA.118.036426
22. Chapman AR, Fujisawa T, Lee KK, Andrews JP, Anand A, Sandeman D, Ferry AV, Stewart S, Marshall L, Strachan FE, Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome. Heart 2019 105 616 622. doi: 10.1136/heartjnl-2018-314093
23. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, ESC Committee for Practice Guidelines ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011 32 2999 3054. doi: 10.1093/eurheartj/ehr236
24. Scottish Intercollegiate Guidelines Network SIGN 93: Acute Coronary Syndromes. https://www.acutemedicine.org.uk/wp-content/uploads/2015/12/SIGN-Acute-Coronary-Syndrome-2013.pdf. Accessed July 1, 2019
25. Ford I, Shah AS, Zhang R, McAllister DA, Strachan FE, Caslake M, Newby DE, Packard CJ, Mills NL, High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease. J Am Coll Cardiol 2016 68 2719 2728. doi: 10.1016/j.jacc.2016.10.020
26. Sandoval Y, Smith SW, Shah AS, Anand A, Chapman AR, Love SA, Schulz K, Cao J, Mills NL, Apple FS, Rapid rule-out of acute myocardial injury using a single high-sensitivity cardiac troponin I measurement. Clin Chem 2017 63 369 376. doi: 10.1373/clinchem.2016.264523
27. Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, Cruikshank A, Reid A, Stoddart M, Strachan F, High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 2015 350 g7873. doi: 10.1136/bmj.g7873
28. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons; Biomarker Subcommittee; ECG Subcommittee; Imaging Subcommittee; Classification Subcommittee; Intervention Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; ESC Committee for Practice Guidelines (CPG); Document Reviewers Third universal definition of myocardial infarction. J Am Coll Cardiol 2012 60 1581 1598. doi: 10.1016/j.jacc.2012.08.001
29. Brown LD, Cai TT, DasGupta A, Interval estimation for a binomial proportion. Statistical Science 2001 16 101 117
30. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, ACC/AHA Task Force Members; Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 130 2354 2394. doi: 10.1161/CIR.0000000000000133
31. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, Moehring B, Ziller R, Hoeller R, Rubini Gimenez M, One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012 172 1211 1218. doi: 10.1001/archinternmed.2012.3698
32. Rubini Gimenez M, Twerenbold R, Jaeger C, Schindler C, Puelacher C, Wildi K, Reichlin T, Haaf P, Merk S, Honegger U, One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med 2015 128 861 870.e4. doi: 10.1016/j.amjmed.2015.01.046
33. Welsh P, Preiss D, Hayward C, Shah ASV, McAllister D, Briggs A, Boachie C, McConnachie A, Padmanabhan S, Welsh C, Cardiac troponin T and troponin I in the general population. Circulation 2019 139 2754 2764. doi: 10.1161/CIRCULATIONAHA.118.038529
34. Zeller T, Tunstall-Pedoe H, Saarela O, Ojeda F, Schnabel RB, Tuovinen T, Woodward M, Struthers A, Hughes M, Kee F, MORGAM Investigators High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 2014 35 271 281. doi: 10.1093/eurheartj/eht406
35. Blankenberg S, Salomaa V, Makarova N, Ojeda F, Wild P, Lackner KJ, Jørgensen T, Thorand B, Peters A, Nauck M, BiomarCaRE Investigators Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J 2016 37 2428 2437. doi: 10.1093/eurheartj/ehw172
36. Mills NL, Churchhouse AM, Lee KK, Anand A, Gamble D, Shah AS, Paterson E, MacLeod M, Graham C, Walker S, Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011 305 1210 1216. doi: 10.1001/jama.2011.338
37. SCOT-HEART Investigators CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): An open-label, parallel-group, multicentre trial. Lancet 2015 385 2383 2391. doi: 10.1016/S0140-6736(15)60291-4
38. Hollander JE, Than M, Mueller C, State-of-the-art evaluation of emergency department patients presenting with potential acute coronary syndromes. Circulation 2016 134 547 564. doi: 10.1161/CIRCULATIONAHA.116.021886
39. Welsh P, Preiss D, Shah ASV, McAllister D, Briggs A, Boachie C, McConnachie A, Hayward C, Padmanabhan S, Welsh C, Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort. Clin Chem 2018 64 1607 1616. doi: 10.1373/clinchem.2018.292086
40. Neumann JT, Sörensen NA, Ojeda F, Schwemer T, Lehmacher J, Gönner S, Jarsetz N, Keller T, Schaefer S, Renné T, Immediate rule-out of acute myocardial infarction using electrocardiogram and baseline high-sensitivity troponin I. Clin Chem 2017 63 394 402. doi: 10.1373/clinchem.2016.262659
41. Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, Yeoh SE, Wallace W, Salter D, Fletcher AM, 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 2014 383 705 713. doi: 10.1016/S0140-6736(13)61754-7
42. Chin CW, Shah AS, McAllister DA, Cowell JS, Alam S, Langrish JP, Strachan FE, Hunter AL, Choy MA, Lang CC, High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur Heart J 2014 35 2312 2321. doi: 10.1093/eurheartj/ehu189
43. Anand A, Chin C, Shah ASV, Kwiecinski J, Vesey A, Cowell J, Weber E, Kaier T, Newby DE, Dweck M, Cardiac myosin-binding protein C is a novel marker of myocardial injury and fibrosis in aortic stenosis. Heart 2018 104 1101 1108. doi: 10.1136/heartjnl-2017-312257
44. Lee KK, Mills NL, High-sensitivity troponin: a barometer for cardiac health. Cardiovasc Res 2018 114 e36 e38. doi: 10.1093/cvr/cvy080
45. Carlton E, Campbell S, Ingram J, Kandiyali R, Taylor H, Aziz S, Beresford P, Kendall J, Reuben A, Smith J, Randomised controlled trial of the Limit of Detection of Troponin and ECG Discharge (LoDED) strategy versus usual care in adult patients with chest pain attending the emergency department: study protocol. BMJ Open 2018 8 e025339. doi: 10.1136/bmjopen-2018-025339
46. Sandoval Y, Nowak R, deFilippi CR, Christenson RH, Peacock WF, McCord J, Limkakeng AT, Sexter A, Apple FS, Myocardial infarction risk stratification with a single measurement of high-sensitivity troponin I. J Am Coll Cardiol 2019 74 271 282. doi: 10.1016/j.jacc.2019.05.058
47. Shah ASV, Sandoval Y, Noaman A, Sexter A, Vaswani A, Smith SW, Gibbins M, Griffiths M, Chapman AR, Strachan FE, Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study. BMJ 2017 359 j4788. doi: 10.1136/bmj.j4788